AstraZeneca pays $1.2B to partner on CSPC obesity & diabetes meds

AstraZeneca's deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly's obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies.

Editor's Pick

Top Story AstraZeneca Beefs Up in Metabolic Disease, Paying $1.2B to Partner on CSPC Obesity & Diabetes Meds AstraZeneca's deal with CSPC Pharmaceutical Group includes a Phase 1-ready obesity drug that hits the same targets as Eli Lilly's obesity drug Zepbound, but with monthly dosing. The new collaboration builds on an existing drug R&D relationship between the two companies. Sponsored How Can AI Support Dental Service Organizations? Presented by Overjet There is a growing demand for advanced technology integration, such as AI tools for clinical decision support, for example, to improve patient care and DSO efficiency.  Get insights on how DSO can benefit with Overjet's AI applications. Click here to learn more.

Featured News

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For instance, Aidoc, Suki and Particle Health named new executives. There were also layoffs at organizations including Takeda, Trinity Health and Horizon BCBS New Jersey. 4 Notable Health Tech Funding Announcements in January Health tech companies made several major funding announcements in January. Here is a list of some of the biggest funding rounds. Harnessing Clinical Expertise to Unlock Hospital Capacity The true foundation of capacity isn't only laid with steel and glass; it's also built through investment in platforms and processes, and benchmarks that prevent those beds from being needed in the first place. Humanized AI: No Longer Optional for Digital Patient Engagement The opportunity ahead is significant. Humanized AI can close the gaps that lead to disengagement, improve outcomes through proactive communication, and give providers the bandwidth to focus where they're needed most.

Video   Video: Inside a New Recursion Drug Katie Couric lost her husband to colon cancer in 1998. Nearly 30 years later, colon cancer rates are rising sharply, especially among younger people, and scientists still don't fully understand why. Watch Couric chat with Najat Khan, CEO of Recursion Pharmaceuticals. Recursion is using AI to identify a promising compound that targets the underlying biology of the disease.

Sponsored Omaha ABA Therapy: Comparing the Top Providers Presented by Stride Autism Centers The right provider enables children to gain confidence, learn to express their needs and discover new ways to connect with the world around them. Learn More

Resources

sponsored Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health Presented by Esperion In a recent interview, Esperion President and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company's expansion into new diseases. Read more

MedCity News • PO Box 901 • New York, NY unsubscribe

The startups aiming to speed endometriosis diagnoses

Scientists are hunting for biomarkers in blood, menstrual fluid, spit, and stool. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

January 31, 2026 Check out STAT+

Sponsored By

A five-letter fruit that may cause a pucker? Solve the latest STAT Mini crossword, with new puzzles every weekday. Thanks for reading.

Sophie Park for STAT STAT+ | Endometriosis often takes years to diagnose. Startups want to change that Diagnosing endometriosis still often requires a surgical procedure. Researchers, startups are testing blood and genetic markers to change that By Theresa Gaffney David Berding/Getty Images Alex Pretti remembered by health care workers at a Minneapolis vigil as a 'stand-up guy' At Minneapolis vigil for Alex Pretti, ICU nurse shot by federal agents, health workers describe grief and a public health crisis By Megan Molteni Constanza Hevia for STAT Tenuous biomedical funding has put first-year Ph.D. students in a bind As NIH and NSF funding tightens, first-year Ph.D. students face delays and detours that could reshape who stays in academic science. By Jonathan Wosen STAT+ | How Opvee, Indivior's powerful overdose antidote, went bust Opvee, more powerful than Narcan, came with significant withdrawal risks. A look at how the harm reduction community worked to get the drug withdrawn. By Lev Facher 9 influencers shaping health information online, for better or worse A look at three categories of wellness influencers — experts, entertainers, and MAHA mobilizers — and how their health content is shaping public opinion. By Alexa Lee How 'gas station drugs' remain legal This week's STATus Report digs into how and why gas stations became the perfect marketplace for quasi-legal "gas station drugs." By Alex Hogan How direct-to-consumer health tests could impact insurance, mortgages, and employment HIPAA applies to hospitals, physician practices and insurers. Startups selling blood panels, genetic tests operate in an unclear privacy environment. By Mohana Ravindranath With new vaccine schedule secured, RFK Jr. allies head to statehouses Opponents of vaccine requirements in day care and school are moving to roll them back in states across the country in the name of "medical freedom." By Daniel Payne and Isabella Cueto STAT+ | Why some hospitals are making their own ChatGPTs for patient records Some large health systems, including Stanford Health Care and Penn Medicine, are building AI-powered chatbots that help clinicians query patients' health records. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser